Dyslipidemia Collection
 141-160 of 376 Articles
Currents |  15 May 1998
Medical Libraries Today
L.M. Asta, MD
Ann Intern Med. 1998;128(10):881-882. doi:10.7326/0003-4819-128-10-199805150-00037
Ideas and Opinions |  15 March 1998
Cholesterol and Violence: Is There a Connection?
Beatrice A. Golomb, MD, PhD
Ann Intern Med. 1998;128(6):478-487. doi:10.7326/0003-4819-128-6-199803150-00009
Original Research |  15 February 1998
The Effect of Estrogen Replacement Therapy on Plasma Nitric Oxide and Endothelin-1 Levels in Postmenopausal Women
Patricia J.M. Best, MD; Peter B. Berger, MD; Virginia M. Miller, PhD; et al.
Ann Intern Med. 1998;128(4):285-288. doi:10.7326/0003-4819-128-4-199802150-00006
Original Research |  15 February 1998
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Howard N. Hodis, MD; Wendy J. Mack, PhD; Laurie LaBree, MS; et al.
Ann Intern Med. 1998;128(4):262-269. doi:10.7326/0003-4819-128-4-199802150-00002
Editorials |  1 June 1997
Is Hypertriglyceridemia a Risk Factor for Atherosclerotic Cardiovascular Disease? A Simple Question with a Complicated Answer
Henry N. Ginsberg, MD
Ann Intern Med. 1997;126(11):912-914. doi:10.7326/0003-4819-126-11-199706010-00012
Original Research |  15 May 1997
Clarifying the Direct Relation between Total Cholesterol Levels and Death from Coronary Heart Disease in Older Persons
Maria-Chiara Corti, MD, MHS; Jack M. Guralnik, MD, PhD; Marcel E. Salive, MD, MPH; et al.
Ann Intern Med. 1997;126(10):753-760. doi:10.7326/0003-4819-126-10-199705150-00001
Reviews |  15 December 1996
Dose-Response Characteristics of Cholesterol-Lowering Drug Therapies: Implications for Treatment
Gordon Schectman, MD; Jan Hiatt, PharmD
Ann Intern Med. 1996;125(12):990-1000. doi:10.7326/0003-4819-125-12-199612150-00011
Original Research |  15 December 1996
Effect of Apheresis of Low-Density Lipoprotein on Peripheral Vascular Disease in Hypercholesterolemic Patients with Coronary Artery Disease
Abraham A. Kroon, MD; Wim N.J.C. van Asten, PhD; Anton F.H. Stalenhoef, MD
Ann Intern Med. 1996;125(12):945-954. doi:10.7326/0003-4819-125-12-199612150-00001
Original Research |  1 November 1996
Twenty-Year Dynamics of Serum Cholesterol Levels in the Middle-Aged Population of Eastern Finland
Pekka Jousilahti, MD, MSc; Erkki Vartiainen, MD, PhD; Jaakko Tuomilehto, MD, PhD, MPolSc; et al.
Ann Intern Med. 1996;125(9):713-722. doi:10.7326/0003-4819-125-9-199611010-00002
Ideas and Opinions |  1 October 1996
Surrogate End Points in Clinical Trials: Are We Being Misled?
Thomas R. Fleming, PhD; David L. DeMets, PhD
Ann Intern Med. 1996;125(7):605-613. doi:10.7326/0003-4819-125-7-199610010-00011
Original Research |  1 October 1996
Effect of Combination Therapy with Lipid-Reducing Drugs in Patients with Coronary Heart Disease and “Normal” Cholesterol Levels: A Randomized, Placebo-Controlled Trial
Richard C. Pasternak, MD; Lisa E. Brown, MPH; Peter H. Stone, MD; et al.
Ann Intern Med. 1996;125(7):529-540. doi:10.7326/0003-4819-125-7-199610010-00001
Ideas and Opinions |  15 September 1996
Lowering Risk without Lowering Cholesterol: Implications for National Cholesterol Policy
Andrew L. Avins, MD, MPH; Warren S. Browner, MD, MPH
Ann Intern Med. 1996;125(6):502-506. doi:10.7326/0003-4819-125-6-199609150-00012
Editorials |  15 May 1996
Lipid Formulations for Amphotericin B: Does the Emperor Need New Clothes?
John R. Graybill, MD
Ann Intern Med. 1996;124(10):921-923. doi:10.7326/0003-4819-124-10-199605150-00011
Ideas and Opinions |  15 May 1996
Cholesterol Reduction: Weighing the Benefits and Risks
J. Michael Gaziano, MD, MPH; Patricia R. Hebert, PhD; Charles H. Hennekens, MD, DrPH
Ann Intern Med. 1996;124(10):914-918. doi:10.7326/0003-4819-124-10-199605150-00009
Original Research |  15 March 1996
Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy: A Randomized, Controlled Clinical Trial
Howard N. Hodis, MD; Wendy J. Mack, PhD; Laurie LaBree, MS; et al.
Ann Intern Med. 1996;124(6):548-556. doi:10.7326/0003-4819-124-6-199603150-00002
Position Papers |  1 March 1996
CLINICAL GUIDELINE, PART 2: Cholesterol Screening in Asymptomatic Adults, Revisited
Alan M. Garber, MD, PhD; Warren S. Browner, MD, MPH; Stephen B. Hulley, MD, MPH
Ann Intern Med. 1996;124(5):518-531. doi:10.7326/0003-4819-124-5-199603010-00013
Position Papers |  1 March 1996
CLINICAL GUIDELINE, PART 1: Guidelines for Using Serum Cholesterol, High-Density Lipoprotein Cholesterol, and Triglyceride Levels as Screening Tests for Preventing Coronary Heart Disease in Adults
American College of Physicians*
Ann Intern Med. 1996;124(5):515-517. doi:10.7326/0003-4819-124-5-199603010-00012
Editorials |  1 March 1996
Evangelists and Snails Redux: The Case of Cholesterol Screening
Frank Davidoff, MD
Ann Intern Med. 1996;124(5):513-514. doi:10.7326/0003-4819-124-5-199603010-00011
Ideas and Opinions |  1 March 1996
Cholesterol Agonistics
John C. LaRosa, MD
Ann Intern Med. 1996;124(5):505-508. doi:10.7326/0003-4819-124-5-199603010-00008
Original Research |  15 February 1996
Hyperlipidemia and Pancreatitis during Pregnancy in Two Sisters with a Mutation in the Lipoprotein Lipase Gene
Leonard M. Keilson, MD, MPH; Calvin P.H. Vary, PhD; Dennis L. Sprecher, MD; et al.
Ann Intern Med. 1996;124(4):425-428. doi:10.7326/0003-4819-124-4-199602150-00007
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.